Correlation Between Madrigal Pharmaceuticals and Cronos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Cronos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Cronos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Cronos Group, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Cronos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Cronos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Cronos.

Diversification Opportunities for Madrigal Pharmaceuticals and Cronos

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Madrigal and Cronos is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Cronos Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cronos Group and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Cronos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cronos Group has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Cronos go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Cronos

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.28 times more return on investment than Cronos. However, Madrigal Pharmaceuticals is 1.28 times more volatile than Cronos Group. It trades about 0.07 of its potential returns per unit of risk. Cronos Group is currently generating about 0.03 per unit of risk. If you would invest  21,671  in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  12,847  from holding Madrigal Pharmaceuticals or generate 59.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Cronos Group

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Cronos Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cronos Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Cronos is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Madrigal Pharmaceuticals and Cronos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Cronos

The main advantage of trading using opposite Madrigal Pharmaceuticals and Cronos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Cronos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will offset losses from the drop in Cronos' long position.
The idea behind Madrigal Pharmaceuticals and Cronos Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies